Michael King
Stock Analyst at EF Hutton
(0.83)
# 2,882
Out of 4,497 analysts
124
Total ratings
28.45%
Success rate
-20.29%
Average return
Main Sectors:
Top Industries:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $11 → $6.5 | $0.21 | +3,017.51% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $147 | $0.85 | +17,241.18% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $4.41 | +149.43% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $5.04 | +534.92% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $20.24 | +238.44% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics | Assumes: Buy | $10 | $0.29 | +3,396.50% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $2.72 | +205.15% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $1,063.60 | -18.95% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $22.60 | +6.19% | 10 | Apr 28, 2023 | |
| OCEA Ocean Biomedical | Maintains: Buy | $10 → $17 | $1.10 | +1,445.45% | 3 | Apr 27, 2023 | |
| AGEN Agenus | Reiterates: Buy | $166 | $5.99 | +2,671.29% | 7 | Mar 28, 2023 | |
| XNCR Xencor | Reiterates: Buy | $42 | $19.14 | +119.44% | 5 | Feb 24, 2023 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $304 | $237.83 | +27.82% | 2 | Feb 24, 2023 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $123 → $116 | $25.08 | +362.52% | 6 | Feb 24, 2023 | |
| CMPX Compass Therapeutics | Initiates: Buy | $10 | $0.94 | +999.49% | 2 | Dec 16, 2022 | |
| VINC Vincerx Pharma | Maintains: Buy | $25 → $28 | $0.65 | +4,207.69% | 2 | Mar 30, 2022 | |
| SRRK Scholar Rock Holding | Initiates: Buy | $24 | $8.71 | +175.55% | 1 | Mar 23, 2022 | |
| SLRX Salarius Pharmaceuticals | Maintains: Buy | $1,000 → $800 | $1.83 | +43,615.85% | 2 | Mar 11, 2022 | |
| ANAB AnaptysBio | Maintains: Buy | $43 → $46 | $33.70 | +36.50% | 2 | Mar 8, 2022 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $98 → $96 | $46.61 | +105.96% | 6 | Mar 3, 2022 | |
| KTRA Kintara Therapeutics | Maintains: Buy | $300 → $150 | $0.25 | +59,400.20% | 2 | Jan 20, 2022 | |
| XLO Xilio Therapeutics | Initiates: Buy | $36 | $0.97 | +3,611.34% | 1 | Jan 10, 2022 | |
| ELEV Elevation Oncology | Initiates: Buy | $12 | $2.64 | +354.55% | 1 | Dec 23, 2021 | |
| COGT Cogent Biosciences | Maintains: Buy | n/a | $8.61 | - | 2 | Nov 5, 2021 | |
| ARGX argenx SE | Maintains: Market Outperform | n/a | $471.32 | - | 2 | Nov 13, 2017 | |
| SYRS Syros Pharmaceuticals | Upgrades: Market Outperform | n/a | $6.27 | - | 2 | Sep 28, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $11 → $6.5
Current: $0.21
Upside: +3,017.51%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $147
Current: $0.85
Upside: +17,241.18%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $4.41
Upside: +149.43%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $5.04
Upside: +534.92%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $20.24
Upside: +238.44%
Coeptis Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.29
Upside: +3,396.50%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $2.72
Upside: +205.15%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $1,063.60
Upside: -18.95%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $22.60
Upside: +6.19%
Ocean Biomedical
Apr 27, 2023
Maintains: Buy
Price Target: $10 → $17
Current: $1.10
Upside: +1,445.45%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $5.99
Upside: +2,671.29%
Xencor
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $19.14
Upside: +119.44%
Alnylam Pharmaceuticals
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $237.83
Upside: +27.82%
Intellia Therapeutics
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $25.08
Upside: +362.52%
Compass Therapeutics
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $0.94
Upside: +999.49%
Vincerx Pharma
Mar 30, 2022
Maintains: Buy
Price Target: $25 → $28
Current: $0.65
Upside: +4,207.69%
Scholar Rock Holding
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $8.71
Upside: +175.55%
Salarius Pharmaceuticals
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.83
Upside: +43,615.85%
AnaptysBio
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $33.70
Upside: +36.50%
Agios Pharmaceuticals
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $46.61
Upside: +105.96%
Kintara Therapeutics
Jan 20, 2022
Maintains: Buy
Price Target: $300 → $150
Current: $0.25
Upside: +59,400.20%
Xilio Therapeutics
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.97
Upside: +3,611.34%
Elevation Oncology
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $2.64
Upside: +354.55%
Cogent Biosciences
Nov 5, 2021
Maintains: Buy
Price Target: n/a
Current: $8.61
Upside: -
argenx SE
Nov 13, 2017
Maintains: Market Outperform
Price Target: n/a
Current: $471.32
Upside: -
Syros Pharmaceuticals
Sep 28, 2017
Upgrades: Market Outperform
Price Target: n/a
Current: $6.27
Upside: -